Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival

Mary A. Wood, Benjamin R. Weeder, Julianne K. David, Abhinav Nellore, Reid Thompson

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival'. Together they form a unique fingerprint.

Medicine & Life Sciences